By Editorial Staff In the complex and often grueling landscape of metastatic breast cancer (MBC) research and...
Sagoh
In a strategic move to strengthen its footprint in the non-opioid pain management market, medical technology giant...
In a significant leap forward for neurocritical care, the US Food and Drug Administration (FDA) has granted...
By Jonathan Gardner | Published June 30, 2026 The U.S. Food and Drug Administration (FDA) is grappling...
In the complex journey of breast cancer survivorship, reconstructive surgery serves as a vital milestone for many...
The global pursuit of health equity is at a critical, and perhaps perilous, juncture. According to the...
In the rapidly expanding landscape of Alabama’s biotechnology sector, a quiet revolution is taking place—not just in...
The Weight-Loss Revolution and the Operating Room: Navigating GLP-1 Risks in Body Contouring Surgery
The Weight-Loss Revolution and the Operating Room: Navigating GLP-1 Risks in Body Contouring Surgery
As the medical community witnesses a meteoric rise in the prescription of glucagon-like peptide-1 (GLP-1) receptor agonists—such...
Introduction: The State of the Mission As the 2026 grant cycle officially commences, METAvivor—a leading voice in...
Published: June 28, 2026 In the age of hyper-curated digital identities, "shadow work" has emerged as a...
